 Hill Contributing Editor Kathleen Koch talking to Dr. Mark McClellan. Several legislative proposals and steps that FDA is trying to implement to get more data and transparency. That QMM program I mentioned, that's about kind of the quality of manufacturers, which would really help with supporting these kinds of contracts. I think the challenge is that that program isn't very well funded now, and you heard Dr. Bouchon talk about